Your trusted source for investing success

Tag: initial public offering

Looking for Cannabis Stocks?

Read our report to find market data, important news and stocks to watch!

UroGen Reports Fourth Quarter and Full Year 2017 Financial Results

UroGen Pharma (Nasdaq:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with a focus on uro-oncology, today announced financial results for the fourth quarter and full year ended December 31, 2017 and provided an overview of the Company’s recent developments.

As quoted in the


Ablynx (Nasdaq: ABLX) today announced its financial results for the year ended 31st December 2017, which have been prepared in accordance with IFRS as issued by the IASB and adopted by the European Union, business highlights year-to-date and the outlook for the remainder of the year.

As quoted in the press release:
Dr Edwin

Motus GI Announces Closing of Initial Public Offering

Motus GI (NASDAQ: MOTS) a medical technology company dedicated to improving endoscopy outcomes and experiences, announced today the closing of its initial public offering of 3,500,000 shares of its common stock at a public offering price of $5.00 per share, with gross proceeds of $17.5 million. Additionally, Motus has granted the

Motus Goes Public on the NASDAQ

Motus Goes Public on the NASDAQ

Medical device company, Motus (NASDAQ:MOTS), made the switch from private to public today on the NASDAQ Capital market, but Renaissance Capital stated the company’s initial public offering (IPO) on the low side of $5 instead of a high of $7.

Enter Your Log In Credentials
This setting should only be used on your home or work computer.


Privacy & Legal Policy

Privacy Policy

Investing News Network

Send this to a friend

I thought you might find this interesting:
Cannabis Weekly Round-Up: US Operator Launches on the CSE